Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FV9V1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,818
Award facts
- Contract value 100% obligated
- $33,817.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) valued at $33,817.87 under a firm fixed-price contract type. The contract was competitively awarded without a set-aside designation and is scheduled for completion by August 27, 2025. RINVOQ is a JAK inhibitor used primarily for rheumatoid arthritis and other inflammatory conditions, reflecting the federal government's ongoing pharmaceutical procurement needs for military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency programs and other government healthcare systems worldwide. The company's facility of performance is located in Conshohocken, Pennsylvania, where it maintains its corporate headquarters.
Quick answers
Who was awarded contract SPE2DB25FV9V1?
SPE2DB25FV9V1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 26, 2025.
How much is contract SPE2DB25FV9V1 worth?
The government has obligated $33,818 on SPE2DB25FV9V1.
Is contract SPE2DB25FV9V1 an order under another contract?
Yes. SPE2DB25FV9V1 is a delivery order under SPE2DB20D3104, an indefinite delivery contract.
Was contract SPE2DB25FV9V1 competed?
The extent of competition for SPE2DB25FV9V1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award